EIF2AK2 and inflammatory bowel disease: Type I and III interferons, which induce PKR expression and autophagy as well as suppressing inflammasome activity, are protective of DSS-induced colitis in mice (4, 5, 67, 68) and so might be trialled as a treatment for IBD.